QTTB vs RARE · rev $53.7M vs rev $350.0M
Q32 Bio Inc (QTTB) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Q32 Bio Inc (QTTB) is a biotechnology company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported QTTB revenue for 2025-12-31 was $53.7M. Net income was $29.8M. QTTB currently screens at market cap $32.4M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
QTTB currently screens at market cap $32.4M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the QTTB and RARE stock pages for the full models.
Not investment advice.